RNAC
Cartesian Therapeutics Inc.
8.10$
+1.8%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -35.49 | -1.75 | -67.52 | -91.72 | -95.13 | -40.65 | 12.41 | -19.01 | -7.81 | -9.90 | -1.00 | -2.85 | |
| 2.42 | 0.08 | 2.75 | 1.32 | 1.57 | 1.60 | 0.26 | 0.39 | 0.32 | 0.16 | 0.05 | 0.11 | |
| 3.42 | 0.09 | 7.04 | 7.19 | 9.19 | 4.08 | 1.93 | 2.43 | 2.76 | 4.36 | 0.28 | 0.41 | |
| 3.96 | 0.10 | 8.65 | 9.54 | 9.62 | 5.03 | 6.01 | 3.49 | -2.19 | – | – | – | |
| -5.84 | 0.03 | 45.29 | 12.55 | -1.26 | -3.54 | 30.24 | -15.18 | -14.90 | 0.96 | -0.24 | -0.31 | |
| 0.64 | 0.09 | 2.01 | 1.29 | 1.42 | 0.04 | 0.29 | 0.34 | 0.30 | 0.04 | 0.38 | 0.21 | |
| -0.64 | -0.36 | -75.82 | -3.70 | 40.64 | 0.18 | -0.26 | -5.40 | -3.70 | 6.69 | -0.37 | -0.21 | |
| – | – | 15.66 | 44.86 | – | 0.02 | 0.07 | – | – | – | – | – | |
| 0.38 | 2.55 | 246.18 | 0.32 | 0.32 | 0.02 | 0.07 | 0.05 | 0.05 | -1.19 | 0.00 | – | |
| 12.57 | 0.89 | 27.52 | 14.14 | -4.50 | -2.21 | 0.37 | 0.00 | 0.00 | -5.31 | 0.00 | – | |
| 69.30 | 3.41 | 232.11 | 116.37 | 1.12 | 83.02 | 5.13 | 16.66 | 9.68 | -2.54 | 7.11 | -0.31 | |
| 23.88 | 1.30 | 88.77 | 21.09 | -53.54 | 41.71 | 17.26 | -7.75 | -1.83 | -5.75 | 5.74 | -3.37 | |
| -36.12 | -1.84 | -69.53 | -93.01 | -96.55 | -40.69 | 12.12 | -19.35 | -8.10 | -9.93 | -1.38 | -3.06 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.